Steven J. Buhaly - 08 Feb 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship
Chief Financial Officer
Issuer ticker
BSGM
Reported as of
08 Feb 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Feb 2023, 11:25:29 UTC
Prior SEC filing
07 Feb 2023
Next SEC filing
17 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Steve Buhaly

Key filing fact

Steven J. Buhaly filed Form 4 for BioSig Technologies, Inc. (BSGM) on 08 Feb 2023.

Key facts

  • This page summarizes Steven J. Buhaly's Form 4 filing for BioSig Technologies, Inc. (BSGM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Feb 2023, 11:25.

Change

  • Previous filing in this sequence was filed on 07 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSGM transaction

Common Stock

Purchase

Transaction value
Shares
+232,882
Change %
Price
Shares after
232,882
Date
08 Feb 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSGM transaction Derivative

Warrants (right to buy)

Purchase

Transaction value
Shares
+116,441
Change %
Price
Shares after
116,441
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
116,441
Exercise price
$0.7963
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The combined purchase price for a share of common stock and the accompanying warrant to purchase 0.5 of a share was $0.8588.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .